Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for SEGA associated with TSC
NCT00789828Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of everolimus in subependymal giant cell astrocytoma (SEGA), sponsored by Novartis. Started Aug 2009; status: completed.
02
Drugs
everolimus
03
Conditions
subependymal giant cell astrocytoma (SEGA)
Beyond the preview
Go deeper on NCT00789828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789828.